These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29253778)

  • 1. Characterization and quantitative analysis of related substances in Coenzyme A by HPLC and LC-MS/MS.
    Yang Y; Lian Y; Zhong P; Wang D; Di B; Li B
    J Pharm Biomed Anal; 2018 Feb; 150():220-232. PubMed ID: 29253778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR.
    Djabrouhou N; Guermouche MH
    J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of related substances in pomalidomide by hyphenated LC-MS techniques.
    Lu P; Wang L; Song M; Hang TJ
    J Pharm Biomed Anal; 2015 Oct; 114():159-67. PubMed ID: 26048668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of related substances in alogliptin benzoate by LC-QTOF mass spectrometric techniques.
    Lu Y; Yang D; Li Z; Hang T; Song M
    J Pharm Biomed Anal; 2016 Sep; 128():253-263. PubMed ID: 27281581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of related substances in tofacitinib citrate by LC-MS techniques for synthetic process optimization.
    Wu X; Zeng X; Wang L; Hang T; Song M
    J Pharm Biomed Anal; 2017 Sep; 143():17-25. PubMed ID: 28549242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
    Chitturi SR; Somannavar YS; Peruri BG; Nallapati S; Sharma HK; Budidet SR; Handa VK; Vurimindi HB
    J Pharm Biomed Anal; 2011 Apr; 55(1):31-47. PubMed ID: 21316175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
    Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS characterization of forced degradation products of zofenopril.
    Ramesh T; Nageswara Rao P; Nageswara Rao R
    J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-Indicating Related Substances HPLC Method for Droxidopa and Characterization of Related Substances Using LC-MS and NMR.
    Kumar T; Ramya M; Arockiasamy Xavier SJ
    J Chromatogr Sci; 2016 Nov; 54(10):1761-1770. PubMed ID: 27601041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
    Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
    J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.
    Venugopal N; Bhaskar Reddy AV; Gangadhar Reddy K; Madhavi V; Madhavi G
    J Pharm Biomed Anal; 2012 Nov; 70():592-7. PubMed ID: 22749172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
    Liu M; Wang J; Liu P
    J Pharm Biomed Anal; 2016 Nov; 131():429-435. PubMed ID: 27661436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
    Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
    Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.